DSCSA 2026: What Pharmaceutical Shippers Must Do Now

How to Meet DSCSA 2026 Requirements

The Drug Supply Chain Security Act (DSCSA) has been reshaping pharmaceutical distribution since 2013. For most companies, the earlier phases felt manageable. Lot-level tracing, transaction documentation, and basic serialization requirements were achievable with incremental investments. The 2026 deadline is different.

Starting in November 2026, trading partners must exchange product tracing data at the unit level using interoperable electronic systems. Manual processes, PDFs, and email-based documentation no longer satisfy the requirement. Every licensed distributor, manufacturer, and dispenser must connect to an electronic network capable of passing and receiving standardized data in real time.

What Changed and When

DSCSA has rolled out in phases since its passage under the Drug Quality and Security Act. The 2023 deadline introduced enhanced drug distribution security requirements. The FDA granted a one-year stabilization period to give the industry time to build compliant systems. That window closes in 2026.

The 2026 requirements add three critical obligations. First, trading partners must use interoperable electronic systems meeting FDA-specified data standards, including EPCIS (Electronic Product Code Information Services). Second, all product verification must happen at the saleable unit level, not lot level. Third, authorized trading partner status must be confirmed before any transaction takes place.

Who Bears the Compliance Burden

Every party in the pharmaceutical supply chain carries an obligation. Manufacturers must serialize products and transmit data at the time of shipment. Wholesale distributors must receive, store, and forward that data with every transfer. Dispensers must verify the product before accepting inventory. Third-party logistics providers handling regulated products must also meet requirements for their segment.

Many smaller distributors and specialty logistics providers are behind on readiness. Companies that assumed compliance was someone else's responsibility are now discovering that their trading partners will refuse shipments that lack proper electronic documentation.

The Serialization Gap

Serialization is necessary but no longer sufficient on its own. A product can carry a compliant 2D barcode and still fail DSCSA 2026 requirements if the transaction data is not transmitted electronically to the next trading partner. The barcode enables verification. The electronic data exchange enables traceability. Both are required.

Companies that invested heavily in serialization but deferred system integration work now face a compressed timeline for closing that gap. Connecting internal systems to external networks, mapping data to EPCIS standards, and testing with trading partners all require lead time that is running short.

Practical Steps Shippers Must Take Now

Readiness for 2026 is not a single project. It is a set of parallel workstreams that each require attention before enforcement begins.

Start with an authorized trading partner audit. Every company in your distribution network must hold current licensure and be verified before transactions occur. Build this check into your onboarding and renewal process rather than treating it as a one-time review.

Assess your data exchange infrastructure. If your current system produces transaction history in PDF or flat file format, it does not meet the 2026 standard. Work with your technology vendor or logistics partner to identify the fastest path to compliant electronic data exchange.

Test with your actual trading partners. System-to-system interoperability sounds straightforward until you run the first test. Edge cases, mapping errors, and timing gaps emerge during testing that never appear in vendor demonstrations. Build in time for multiple test cycles before the compliance deadline.

Develop a response plan for verification failures. DSCSA requires trading partners to quarantine and investigate product that cannot be verified. Your pharmaceutical distribution team needs a documented process for handling these situations before they happen under pressure.

Chain of Custody in a Compliant Network

Full drug traceability under DSCSA 2026 is essentially a formalized chain-of-custody requirement applied across every transaction in the supply chain. Every handoff must be documented. Every record must be retrievable within 24 hours of an FDA request. The difference from traditional practice is the requirement for electronic interoperability rather than paper-based documentation.

Good Distribution Practice principles have always called for documented, controlled product transfer. DSCSA 2026 enforces those principles with specific technical standards and legal obligations attached. Companies that already operate to GDP standards have a foundation to build on. But foundation is not finish line.

How Mercury Helps

Mercury works with pharmaceutical shippers, clinical research organizations, and specialty drug distributors across the United States. Our logistics workflows are built for regulated product, which means documentation, custody records, and handling requirements are not afterthoughts.

Our specialty cold-chain and parcel services support temperature-controlled pharmaceutical distribution with continuous monitoring and complete custody documentation. We understand that every shipment represents a compliance event as much as a delivery.

As DSCSA 2026 requirements come into effect, Mercury clients benefit from a logistics partner that operates within regulated frameworks rather than around them. We build workflows that hold up under regulatory scrutiny rather than shortcuts that create exposure.

Our team operates around the clock, every day of the year. When a shipment requires rapid verification, quarantine support, or emergency rerouting, Mercury responds with the speed and documentation that pharmaceutical logistics demands.

Visit our blog and glossary for more resources on pharmaceutical supply chain compliance, or contact Mercury today to align your logistics operations with DSCSA 2026 requirements before enforcement begins.